Citation

86 FR 314

Canonical document for this Federal Register citation.

Investigational New Drug Submissions for Individualized Antisense Oligonucleotide Drug Products: Administrative and Procedural Recommendations; Draft Guidance for Sponsor-Investigators; Availability Tuesday, January 5, 2021 86 FR 314